119 related articles for article (PubMed ID: 16108245)
1. Bisphosphonate-associated scleritis: a case report and review.
Leung S; Ashar BH; Miller RG
South Med J; 2005 Jul; 98(7):733-5. PubMed ID: 16108245
[TBL] [Abstract][Full Text] [Related]
2. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
French DD; Margo CE
Retina; 2008 Jun; 28(6):889-93. PubMed ID: 18536608
[TBL] [Abstract][Full Text] [Related]
3. Nodular scleritis following alendronate therapy.
Tabbara KF
Ocul Immunol Inflamm; 2008; 16(3):99-101. PubMed ID: 18569796
[TBL] [Abstract][Full Text] [Related]
4. Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report.
Tian Y; Wang R; Liu L; Ma C; Lu Q; Yin F
BMC Musculoskelet Disord; 2016 Feb; 17():72. PubMed ID: 26867651
[TBL] [Abstract][Full Text] [Related]
5. [Bisphosphonate-induced ocular and orbital inflammation].
Jakobsen TS; Funding M
Ugeskr Laeger; 2022 Jul; 184(28):. PubMed ID: 35959811
[TBL] [Abstract][Full Text] [Related]
6. Ocular side effects associated with bisphosphonates.
Fraunfelder FW
Drugs Today (Barc); 2003 Nov; 39(11):829-35. PubMed ID: 14702129
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
[TBL] [Abstract][Full Text] [Related]
8. Ocular Side Effects of Bisphosphonates: A Review of Literature.
Chartrand NA; Lau CK; Parsons MT; Handlon JJ; Ronquillo YC; Hoopes PC; Moshirfar M
J Ocul Pharmacol Ther; 2023; 39(1):3-16. PubMed ID: 36409537
[TBL] [Abstract][Full Text] [Related]
9. [Osteoporosis and bisphosphonates].
Zuber MA
Z Rheumatol; 2007 Dec; 66(8):713-5. PubMed ID: 17955251
[No Abstract] [Full Text] [Related]
10. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced ocular inflammation.
Samalia P; Sims J; Niederer R
N Z Med J; 2020 Dec; 133(1527):83-94. PubMed ID: 33332330
[TBL] [Abstract][Full Text] [Related]
12. Risedronate-associated scleritis: a case report and review of the literature.
Hemmati I; Wade J; Kelsall J
Clin Rheumatol; 2012 Sep; 31(9):1403-5. PubMed ID: 22864810
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates and atrial fibrillation.
Prescrire Int; 2008 Aug; 17(96):161. PubMed ID: 19492493
[No Abstract] [Full Text] [Related]
14. Osteoporosis treatment and atrial fibrillation: alendronate versus raloxifene.
Huang WF; Tsai YW; Wen YW; Hsiao FY; Kuo KN; Tsai CR
Menopause; 2010; 17(1):57-63. PubMed ID: 19680161
[TBL] [Abstract][Full Text] [Related]
15. Ocular inflammation associated with alendronate therapy.
Mbekeani JN; Slamovits TL; Schwartz BH; Sauer HL
Arch Ophthalmol; 1999 Jun; 117(6):837-8. PubMed ID: 10369603
[No Abstract] [Full Text] [Related]
16. Ocular side effects of bisphosphonates: A case report and literature review.
McKague M; Jorgenson D; Buxton KA
Can Fam Physician; 2010 Oct; 56(10):1015-7. PubMed ID: 20944044
[No Abstract] [Full Text] [Related]
17. Do not use bisphosphonate therapy indefinitely for fracture prevention.
Prescrire Int; 2008 Oct; 17(97):214. PubMed ID: 19536944
[TBL] [Abstract][Full Text] [Related]
18. Corneal graft rejection precipitated by uveitis secondary to alendronate sodium therapy.
Richards JC; Wiffen SJ
Cornea; 2006 Oct; 25(9):1100-1. PubMed ID: 17133063
[TBL] [Abstract][Full Text] [Related]
19. Alendronate: a bisphosphonate for treatment of osteoporosis.
Kirk JK; Spangler JG
Am Fam Physician; 1996 Nov; 54(6):2053-60. PubMed ID: 8900364
[TBL] [Abstract][Full Text] [Related]
20. [Alendronate].
Lindberg M
Ugeskr Laeger; 1998 Oct; 160(44):6367-8. PubMed ID: 9810249
[No Abstract] [Full Text] [Related]
[Next] [New Search]